Literature DB >> 25551863

Frequency and impact of informant replacement in Alzheimer disease research.

Joshua D Grill1, Yan Zhou, Jason Karlawish, David Elashoff.   

Abstract

Informants serve an essential role in Alzheimer disease research. Were an informant to be replaced during a longitudinal study, this could have negative implications. We used data from the National Alzheimer's Coordinating Center Uniform Data Set to examine the frequency of informant replacement among Alzheimer disease dementia participants, whether patient and informant characteristics were associated with replacement, and how replacement affected research outcome measures. Informant replacement was common (15.5%) and typically occurred after the first or the second research visit. Adult child (24%) and other (38%) informants were more frequently replaced than spouse informants (10%). Older spouse informant age and younger adult child informant age were associated with replacement. The between-visit change in Functional Assessment Questionnaire scores was greater in patients who replaced informants than in those with stable informants. Clinical Dementia Rating-Sum of Boxes, Functional Assessment Questionnaire, and Neuropsychiatric Inventory scores showed greater variability in between-visit change in patients who replaced informants compared with those with stable informants. These findings suggest that informant replacement is relatively common, may have implications to study analyses, and warrant further examination in the setting of clinical trials.

Entities:  

Mesh:

Year:  2015        PMID: 25551863      PMCID: PMC4486637          DOI: 10.1097/WAD.0000000000000078

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  33 in total

Review 1.  Recruitment and retention of latino dementia family caregivers in intervention research: issues to face, lessons to learn.

Authors:  Dolores Gallagher-Thompson; Nancy Solano; David Coon; Patricia Areán
Journal:  Gerontologist       Date:  2003-02

2.  An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  D Galasko; D Bennett; M Sano; C Ernesto; R Thomas; M Grundman; S Ferris
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

3.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

4.  The value of informant versus individual's complaints of memory impairment in early dementia.

Authors:  D B Carr; S Gray; J Baty; J C Morris
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

5.  Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials?

Authors:  Joshua D Grill; Sarah Monsell; Jason Karlawish
Journal:  Dement Geriatr Cogn Disord       Date:  2012-07-02       Impact factor: 2.959

6.  Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease.

Authors:  Richard C Mohs; Claudia Kawas; Maria C Carrillo
Journal:  Alzheimers Dement       Date:  2006-07       Impact factor: 21.566

7.  Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?

Authors:  Mark S Cary; Jonathan D Rubright; Joshua D Grill; Jason Karlawish
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

Review 8.  Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future.

Authors:  Warachal E Faison; Susan K Schultz; Jeroen Aerssens; Jennifer Alvidrez; Ravi Anand; Lindsay A Farrer; Lissy Jarvik; Jennifer Manly; Thomas McRae; Greer M Murphy; Jason T Olin; Darrel Regier; Mary Sano; Jacobo E Mintzer
Journal:  Int Psychogeriatr       Date:  2007-04-23       Impact factor: 3.878

9.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

10.  Factors related to perceived quality of life in patients with Alzheimer's disease: the patient's perception compared with that of caregivers.

Authors:  Josep Lluís Conde-Sala; Josep Garre-Olmo; Oriol Turró-Garriga; Secundino López-Pousa; Joan Vilalta-Franch
Journal:  Int J Geriatr Psychiatry       Date:  2009-06       Impact factor: 3.485

View more
  5 in total

1.  Consider the Source: The Implications of Informant Type on Outcome Assessments.

Authors:  Joshua D Grill; Jason Karlawish
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Oct-Dec       Impact factor: 2.703

2.  Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role.

Authors:  Betty S Black; Holly A Taylor; Peter V Rabins; Jason Karlawish
Journal:  Dementia (London)       Date:  2016-05-13

3.  Study partners: essential collaborators in discovering treatments for Alzheimer's disease.

Authors:  Emily A Largent; Jason Karlawish; Joshua D Grill
Journal:  Alzheimers Res Ther       Date:  2018-09-27       Impact factor: 6.982

4.  The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations.

Authors:  Rachel L Nosheny; Rebecca Amariglio; Sietske A M Sikkes; Carol Van Hulle; Maria Aparecida Camargos Bicalho; N Maritza Dowling; Sonia Maria Dozzi Brucki; Zahinoor Ismail; Kensaku Kasuga; Elizabeth Kuhn; Katya Numbers; Anna Aaronson; Davide Vito Moretti; Arturo X Pereiro; Gonzalo Sánchez-Benavides; Allis F Sellek Rodríguez; Prabitha Urwyler; Kristina Zawaly
Journal:  Alzheimers Dement (N Y)       Date:  2022-10-04

Review 5.  The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force.

Authors:  Jessica K Roydhouse; Matthew L Cohen; Henrik R Eshoj; Nadia Corsini; Emre Yucel; Claudia Rutherford; Katarzyna Wac; Allan Berrocal; Alyssa Lanzi; Cindy Nowinski; Natasha Roberts; Angelos P Kassianos; Veronique Sebille; Madeleine T King; Rebecca Mercieca-Bebber
Journal:  Qual Life Res       Date:  2021-07-12       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.